Morgan Stanley Portfolio holdings
Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
VanEck Uranium + Nuclear Energy ETF
NLR
$3.02B
| $152M | 0.01% |
1,312,743
+54,323
| +4% | +$7.25M |
2013 Q2
52 quarters
|
|
1227
Jazz Pharmaceuticals
JAZZ
$15.7B
| $152M | 0.01% |
629,680
-69,058
| -10% | -$15.1M |
2013 Q2
52 quarters
|
|
1228
Timken Company
TKR
$7.69B
| $152M | 0.01% |
1,043,434
+221,857
| +27% | +$26.7M |
2013 Q2
52 quarters
|
|
1229
Dropbox
DBX
$7.22B
| $152M | 0.01% |
5,518,521
-733,860
| -12% | -$18.9M |
2018 Q1
33 quarters
|
|
1230
iShares MSCI USA Quality GARP ETF
GARP
$3.5B
| $151M | 0.01% |
1,833,873
+1,035,645
| +130% | +$78.7M |
2025 Q2
4 quarters
|
|
1231
Valvoline
VVV
$4.52B
| $151M | 0.01% |
3,827,602
+119,990
| +3% | +$4.17M |
2016 Q3
39 quarters
|
|
1232
Pricesmart
PSMT
$5.12B
| $151M | 0.01% |
774,749
+289,617
| +60% | +$48.3M |
2013 Q2
52 quarters
|
|
1233
Deutsche Bank
DB
$68.4B
| $151M | 0.01% |
4,481,398
-1,178,588
| -21% | -$38.2M |
2013 Q2
52 quarters
|
|
1234
BrightSpring Health Services
BTSG
$14.5B
| $151M | 0.01% |
2,167,944
+1,103,929
| +104% | +$61.3M |
2024 Q1
9 quarters
|
|
1235
Blackstone Secured Lending
BXSL
$5.52B
| $151M | 0.01% |
6,358,639
+360,669
| +6% | +$8.61M |
2021 Q4
18 quarters
|
|
1236
Structure Therapeutics
GPCR
$1.43B
| $151M | 0.01% |
2,806,640
+501,183
| +22% | +$22.2M |
2023 Q3
11 quarters
|
|
1237
Aptiv
APTV
$7.89B
| $151M | 0.01% |
2,453,903
+108,765
| +5% | +$6.65M |
2013 Q2
52 quarters
|
|
1238
iShares US Infrastructure ETF
IFRA
$4.06B
| $151M | 0.01% |
2,388,778
+81,453
| +4% | +$4.97M |
2021 Q1
21 quarters
|
|
1239
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.02B
| $150M | 0.01% |
6,487,553
-205,278
| -3% | -$4.76M |
2020 Q4
22 quarters
|
|
1240
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
| $150M | 0.01% |
1,025,573
+64,150
| +7% | +$8.96M |
2013 Q2
52 quarters
|
|
1241
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.81B
| $150M | 0.01% |
2,960,883
+432,457
| +17% | +$21.9M |
2019 Q4
26 quarters
|
|
1242
iShares MSCI United Kingdom ETF
EWU
$3.74B
| $150M | 0.01% |
3,246,974
+240,866
| +8% | +$11.3M |
2013 Q2
52 quarters
|
|
1243
Cemex
CX
$15.1B
| $149M | 0.01% |
12,453,125
+1,935,935
| +18% | +$24M |
2013 Q2
52 quarters
|
|
1244
Interparfums
IPAR
$4.19B
| $149M | 0.01% |
1,332,120
+17,955
| +1% | +$1.69M |
2013 Q2
52 quarters
|
|
1245
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.9B
| $149M | 0.01% |
2,905,095
+100,736
| +4% | +$5.16M |
2013 Q2
52 quarters
|
|
1246
Paylocity
PCTY
$9.28B
| $149M | 0.01% |
1,425,020
+88,300
| +7% | +$9.4M |
2014 Q2
48 quarters
|
|
1247
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.6B
| $149M | 0.01% |
1,064,684
+4,782
| +0.5% | +$632K |
2013 Q2
52 quarters
|
|
1248
Conagra Brands
CAG
$6.97B
| $149M | 0.01% |
11,048,944
-3,055,710
| -22% | -$42.7M |
2013 Q2
52 quarters
|
|
1249
Annaly Capital Management
NLY
$14.1B
| $148M | 0.01% |
6,636,749
+160,943
| +2% | +$3.55M |
2013 Q2
52 quarters
|
|
1250
Capital Group Dividend Growers ETF
CGDG
$6.03B
| $148M | 0.01% |
3,945,234
-101,983
| -3% | -$3.79M |
2024 Q1
9 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,806 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.